Basics Rapport Therapeutics, Inc. Common Stock IPO Date: June 7, 2024 Sector: Healthcare Industry: Biotech Market Cap: $1.41B Activated in VL: True Average Daily Range Avg Daily Range: $0.83 | 4.55% Avg Daily Range (30 D): $0.86 | 3.16% Avg Daily Range (90 D): $0.85 | 3.52% Institutional Daily Volume Avg Daily Volume: .23M Avg Daily Volume (30 D): .3M Avg Daily Volume (90 D): .55M Trade Size Avg Trade Size (Sh.): 57 Avg Trade Size (Sh.) (30 D): 49 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 188 Avg Inst. Trade: $1.6M Avg Inst. Trade (30 D): $1.36M Avg Inst. Trade (90 D): $1.47M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.14M Avg Closing Trade (30 D): $1.53M Avg Closing Trade (90 D): $1.86M Avg Closing Volume: 99.64K     News Sep 10, 2025 @ 1:17 AM Rapport Announces Pricing of Public Offering of Co... Source: Globe Newswire Jun 12, 2025 @ 8:22 PM Analysts Can't Get Enough of These Little-Known Bi... Source: Marketbeat.Com Jun 2, 2025 @ 6:45 PM Rapport Therapeutics Hosts Investor and Analyst Da... Source: Rapport Therapeutics, Inc. Mar 21, 2025 @ 11:00 AM Rapport Therapeutics to Present Data at the 2025 A... Source: N/A Jan 9, 2025 @ 12:00 PM Rapport Therapeutics Announces New Phase 1 Data, F... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-2.27 $-.71 $-.75 Diluted EPS $-2.27 $-.71 $-.75 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -97.7M $ -26.93M $ -26.73M Operating Income / Loss $ -110.11M $ -29.99M $ -29.5M Cost of Revenue $ $ $ Net Cash Flow $ 212.05M $ 196.29M $ -2.54M PE Ratio